{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T07:59:36Z","timestamp":1704182376519},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.2169\/internalmedicine.9124-21","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T22:10:03Z","timestamp":1651875003000},"page":"3483-3490","source":"Crossref","is-referenced-by-count":2,"title":["Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms"],"prefix":"10.2169","volume":"61","author":[{"given":"Myung-Won","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hoon","family":"Yeon","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyewon","family":"Ryu","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ik-Chan","family":"Song","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwan-Jung","family":"Yun","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Sook","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deog-Yeon","family":"Jo","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127: 2391-2405, 2016.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","volume":"19","author":"T Rungjirajittranon","year":"2019","unstructured":"2. Rungjirajittranon T, Owattanapanich W, Ungprasert P, Siritanaratkul N, Ruchutrakool T. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms. BMC Cancer 19: 184, 2019.","journal-title":"BMC Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Stein BL, Martin K. From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms. Blood 134: 1902-1911, 2019.","DOI":"10.1182\/blood.2019001318"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mudireddy M, Shah S, Lasho T, et al. Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons. Br J Haematol 182: 594-597, 2018.","DOI":"10.1111\/bjh.14838"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yogarajah M, Tefferi A. Leukemic transformation in myeloproliferative neoplasms: a literature review on risk, characteristics, and outcome. Mayo Clin Proc 92: 1118-1128, 2017.","DOI":"10.1016\/j.mayocp.2017.05.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hong J, Lee JH, Byun JM, et al. Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Blood Adv 3: 3700-3708, 2019.","DOI":"10.1182\/bloodadvances.2019000655"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tremblay D, Schwartz M, Bakst R, et al. Modern management of splenomegaly in patients with myelofibrosis. Ann Hematol 99: 1441-1451, 2020.","DOI":"10.1007\/s00277-020-04069-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee MW, Yeon SH, Ryu H, et al. Volumetric splenomegaly in patients with essential thrombocythemia and prefibrotic\/early primary myelofibrosis. Int J Hematol 114: 35-43, 2021.","DOI":"10.1007\/s12185-021-03121-x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Song MK, Park BB, Uhm JE. Understanding splenomegaly in myelofibrosis: association with molecular pathogenesis. Int J Mol Sci 19: 898, 2018.","DOI":"10.3390\/ijms19030898"},{"key":"10","unstructured":"10. Jaroch MT, Broughan TA, Hermann RE. The natural history of splenic infarction. Surgery 100: 743-750, 1986."},{"key":"11","unstructured":"11. Nores M, Phillips EH, Morgenstern L, Hiatt JR. The clinical spectrum of splenic infarction. Am Surg 64: 182-188, 1998."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Antopolsky M, Hiller N, Salameh S, Goldshtein B, Stalnikowicz R. Splenic infarction: 10 years of experience. Am J Emerg Med 27: 262-265, 2009.","DOI":"10.1016\/j.ajem.2008.02.014"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Conn HO. Sickle-cell trait and splenic infarction associated with high-altitude flying. N Engl J Med 251: 417-420, 1954.","DOI":"10.1056\/NEJM195409092511102"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Boddana PV, Tomson CR, Austen B, et al. A case of lymphoma presenting as splenic infarction. BMJ Case Rep 2009: bcr.09.2008.0849, 2009.","DOI":"10.1136\/bcr.09.2008.0849"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Goldschmidt N, Gural A, Ben Yehuda D. Extensive splenic infarction, deep vein thrombosis and pulmonary emboli complicating induction therapy with all-trans-retinoic acid (ATRA) for acute promyelocytic leukemia. Leuk Lymphoma 44: 1433-1437, 2003.","DOI":"10.1080\/1042819031000076963"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dyer MJ, Majid A, Walewska R, et al. Splenic infarction associated with rapidly progressive chronic lymphocytic leukemia with complex karyotype and ATM mutation. Leuk Res 35: e55-e57, 2011.","DOI":"10.1016\/j.leukres.2010.10.033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Drummond D, Lenoir M, Petit AY. Splenic infarction in a child revealing chronic myeloid leukemia. Eur J Pediatr 171: 1141-1142, 2012.","DOI":"10.1007\/s00431-012-1675-y"},{"key":"18","unstructured":"18. Charan VD. Splenic infarction in polycythemia vera: can the spleen be saved? J Assoc Physicians India 63: 94, 2015."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Downer WR, Peterson MS. Massive splenic infarction and liquefactive necrosis complicating polycythemia vera. AJR Am J Roentgenol 161: 79-80, 1993.","DOI":"10.2214\/ajr.161.1.8517327"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Friedrich EB, Kindermann M, Link A, Bohm M. Splenic rupture complicating periinterventional glycoprotein IIb\/IIIa antagonist therapy for myocardial infarction in polycythemia vera. Z Kardiol 94: 200-204, 2005.","DOI":"10.1007\/s00392-005-0197-2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tzeng CW, Wang YC, Hsieh CH. Peritonitis resulting from ruptured splenic abscess after splenic infarction in a patient with polycythemia vera. Am Surg 78: E474-E475, 2012.","DOI":"10.1177\/000313481207801114"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Passamonti F, Thiele J, Girodon F, et al. A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. Blood 120: 1197-1201, 2012.","DOI":"10.1182\/blood-2012-01-403279"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 113: 2895-2901, 2009.","DOI":"10.1182\/blood-2008-07-170449"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Passamonti F. How I treat polycythemia vera. Blood 120: 275-284, 2012.","DOI":"10.1182\/blood-2012-02-366054"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management. Am J Hematol 95: 1599-1613, 2020.","DOI":"10.1002\/ajh.26008"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tefferi A. Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Am J Hematol 96: 145-162, 2021.","DOI":"10.1002\/ajh.26050"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Mesa RA. How I treat symptomatic splenomegaly in patients with myelofibrosis. Blood 113: 5394-5400, 2009.","DOI":"10.1182\/blood-2009-02-195974"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Cervantes F. How I treat splenomegaly in myelofibrosis. Blood Cancer J 1: e37, 2011.","DOI":"10.1038\/bcj.2011.36"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Wang J, Xu J, Gale RP, et al. Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosis. Leuk Res 38: 1207-1211, 2014.","DOI":"10.1016\/j.leukres.2014.08.006"},{"key":"30","unstructured":"30. Altemeier WA, Macmillan BG. Massive splenic infarction with acute necrosis and abscess following ligation of the hepatic and splenic arteries for portal hypertension; case report. Am Surg 20: 739-743, 1954."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Warrier I, Ravindranath Y. Splenic infarction and total functional asplenia in disseminated varicella. J Pediatr 109: 305-307, 1986.","DOI":"10.1016\/S0022-3476(86)80390-0"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wang CC, Lee CH, Chan CY, Chen HW. Splenic infarction and abscess complicating infective endocarditis. Am J Emerg Med 27: 1021. e3-e5, 2009.","DOI":"10.1016\/j.ajem.2008.12.028"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Krepis P, Maritsi DN, Tsolia MN, Vakaki M, Kossiva L. Massive splenic infarction and autosplencetomy: first presentation of homozygous sickle cell disease in a toddler. J Pediatr Hematol Oncol 42: 371-372, 2020.","DOI":"10.1097\/MPH.0000000000001698"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_9124-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:32:36Z","timestamp":1670038356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_9124-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":33,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9124-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"9124-21"}}